Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Icon Plc (ICLR)

Icon Plc (ICLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,243,675
  • Shares Outstanding, K 80,757
  • Annual Sales, $ 8,282 M
  • Annual Income, $ 791,470 K
  • EBIT $ 1,201 M
  • EBITDA $ 1,690 M
  • 60-Month Beta 1.35
  • Price/Sales 1.01
  • Price/Cash Flow 5.14
  • Price/Book 0.89

Options Overview Details

View History
  • Implied Volatility 72.02% (-2.17%)
  • Historical Volatility 49.77%
  • IV Percentile 99%
  • IV Rank 94.70%
  • IV High 74.19% on 03/27/26
  • IV Low 33.15% on 07/25/25
  • Expected Move (DTE 18) 9.83 (9.36%)
  • Put/Call Vol Ratio 0.43
  • Today's Volume 162
  • Volume Avg (30-Day) 324
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 7,400
  • Open Int (30-Day) 7,564
  • Expected Range 95.27 to 114.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 3.16
  • Number of Estimates 4
  • High Estimate 3.20
  • Low Estimate 3.14
  • Prior Year 3.42
  • Growth Rate Est. (year over year) -7.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.75 +9.77%
on 03/19/26
113.88 -7.71%
on 03/05/26
-3.04 (-2.81%)
since 02/27/26
3-Month
66.57 +57.88%
on 02/12/26
203.91 -48.46%
on 01/07/26
-77.74 (-42.52%)
since 12/26/25
52-Week
66.57 +57.88%
on 02/12/26
211.00 -50.19%
on 07/24/25
-73.97 (-41.31%)
since 03/28/25

Most Recent Stories

More News
Icon Plc Faces Earnings Test After Accounting Scandal and Analyst Downgrades

ICLR : 105.10 (+2.96%)
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model

Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply established global network. ...

ICLR : 105.10 (+2.96%)
ICLR ALERT: Ongoing Investigation Into ICON Public Limited Company - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - March 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company (NASDAQ: ICLR) ("ICON Public Limited...

ICLR : 105.10 (+2.96%)
Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:...

ICLR : 105.10 (+2.96%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

NEW YORK , March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact...

ICLR : 105.10 (+2.96%)
Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:...

ICLR : 105.10 (+2.96%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact...

ICLR : 105.10 (+2.96%)
ICLR INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ICON Public Limited Company

The law firm of Kirby McInerney LLP continues its investigation on behalf of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ:ICLR) investors concerning the Company’s...

ICLR : 105.10 (+2.96%)
Protect Your Investment: Contact Levi & Korsinsky About the ICON Public Limited Company (ICLR) Investigation

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:...

ICLR : 105.10 (+2.96%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact...

ICLR : 105.10 (+2.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

3rd Resistance Point 111.84
2nd Resistance Point 109.37
1st Resistance Point 107.24
Last Price 105.10
1st Support Level 102.63
2nd Support Level 100.16
3rd Support Level 98.02

See More

52-Week High 211.00
Fibonacci 61.8% 155.83
Fibonacci 50% 138.78
Fibonacci 38.2% 121.74
Last Price 105.10
52-Week Low 66.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.